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    We found that quercetin, myricetin, quercetagetin, fisetin, (-)-epigallocatechin 
gallate (EGCG) and theaflavins, among twenty-four flavonoids examined, markedly 
inhibited EGF-induced cell transformation of mouse epidermal JB6 Cl 41 cells.  The 
six flavonoids suppressed the EGF-induced activation of activator protein 1 (AP-1).  In 
addition, myricetin, quercetagetin, EGCG and theaflavins directly inhibited 
EGF-induced phosphatidylinositol 3-kinase (PI3K) activation.  The important 
structural features of flavonoids for cell transformation-inhibitory activity are 3’- and 
4’-OH on the B-ring, 3-OH on the C-ring, C2-C3 double bond in the C-ring, and the 
phenylchromone (C6-C5-C6) skeleton in the flavonols, and the galloyl group in EGCG 
and theaflavins.  Our results provide new insight into possible mechanisms of the 
anti-carcinogenic effects of flavonoids, and could help to provide a basis for the design 
of novel cancer chemopreventive agents. 
 
Key words: flavonoids, cell transformation, signal transduction, AP-1, PI3K 
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INTRODUCTION 
    Flavonoids, which are primarily phenylbenzo-γ-pyrone (phenylchromone) 
derivatives, are polyphenolic compounds present in fruits, vegetables, and beverages [1].  
Numerous studies both in vitro and in animal models have indicated that various 
flavonoids influence important cellular and molecular mechanisms related to 
carcinogenesis, such as cell cycle control, apoptosis and malignant transformation [2-4].  
Many of the biological actions of flavonoids are thought to be attributable to their 
antioxidant properties, including their effects on intracellular redox status [5,6].  
However, it has been suggested that the conventional hydrogen-donating antioxidant 
activity of flavonoids may not be relevant to their biological activities [7-9].  There is 
accumulating evidence that flavonoids modify the activities of several intracellular 
signal transduction enzymes, including mitogen-activated protein kinases (MAPKs), 
and phosphatidylinositol 3-kinase (PI3K) [2,4,7,10].   Several studies have found that 
flavonoids also inhibit the growth of malignant cells [11,12].  It has been shown that 
flavonoids inhibit signal transduction enzymes by competitively blocking the ATP 
binding site [10,13,14], but the structure-activity relationship remains to be fully 
established.  
    The mouse epidermal JB6 cell system of clonal genetic variants, which are 
promotion-sensitive (P+) or promotion-resistant (P-), is an excellent model for studying 
molecular mechanisms in various stages of carcinogenesis [15-20].  The JB6 P+, P- 
and transformed variants are a series of cell lines representing ‘earlier-to-later’ stages of 
preneoplastic-to-neoplastic progression [16,18].  JB6 Cl 41 cells as P+ cells, but not P- 
cells, undergo transformation when stimulated with epidermal growth factor (EGF) or 
12-O-tetradecanoylphorbol-13-acetate (TPA), and form colonies in soft agar [16,18].  
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Through comparison of JB6 P+ and P- cells, the transformation is demonstrated to 
involve activation of activator protein 1 (AP-1) [15,19-22], which regulates the 
transcription of various genes related to cellular inflammation, proliferation and 
apoptosis [23].  AP-1 activation is stimulated, at least in part, by activation of MAPKs, 
such as extracellular signal-regulated kinases (ERKs), c-Jun N-terminal kinases (JNKs), 
and p38 kinases [19,20,24,25].  Inhibition of MAPK activation by dominant negative 
mutants and chemical inhibitors [24] or by some chemopreventive agents [4,26] blocks 
tumor promoter-induced cell transformation of JB6 Cl 41 cells.  In addition, we have 
shown that phosphatidylinositol 3-kinase (PI3K) and its downstream effector, Akt, are 
intimately involved in EGF-induced cell transformation of JB6 Cl 41 cells [27].  PI3K 
is central to the coordinated control of multiple cell-signaling pathways leading to 
tumor development, including cell proliferation, apoptosis and migration [28,29], and 
Akt plays a pivotal role in the PI3K-signaling pathway [30].  Thus, JB6 Cl 41 cells 
provide a well-developed cell culture system for studying the regulation of signal 
transduction by chemopreventive agents in the tumor promotion stage in vitro.  
Therefore, we investigated the structure-activity relationship for inhibition of 
EGF-induced cell transformation in JB6 Cl 41 cells, using 24 flavonoids, including 
flavones, flavonols, isoflavones, flavanones, flavanols, flavanonols, and chalcone (Fig. 
1).  We found that several flavonols markedly inhibited the EGF-induced cell 
transformation.  The active compounds also appeared to inhibit activation of the AP-1 
and PI3K/Akt pathways. 
 
MATERIALS AND METHODS 
Materials 
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    The flavones, flavone, apigenin, luteolin and chrysin, the flavonols, kaempferol, 
quercetin, rutin and morin, the isoflavones, daidzein and genistein, the flavanones, 
hesperetin, hesperidin and naringenin, the flavanonol, silybin, and the flavanols, 
(+)-catechin and EGCG, were purchased from Sigma (St. Louis, MO, USA).  The 
flavonols, galangin, myricetin and quercetagetin, and the chalcone, 
2’,4’,6’,3,4-pentahydroxychalcone, were from Extrasynthese (Genay Cedex, France).  
The flavonol, fisetin, and the flavanol, (-)-catechin, were from Wako Pure Chemical 
Industries, Ltd. (Osaka, Japan).  Theaflavins (flavanol) were from Kurita Industries 
(Tokyo, Japan).  (±)-Taxifolin (flavanonol) was from Calbiochem (San Diego, CA, 
USA).  The structures are shown in Fig. 1a-c.  Eagle's minimum essential medium 
(MEM), fetal bovine serum (FBS), L-glutamine and basal medium Eagle (BME) were 
from Gibco (Invitrogen; Gland Island, NY, USA); EGF, 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), 
phosphatidylinositol and gentamicin were from Sigma; the Akt immunoprecipitation 
kinase assay kit was from Upstate Biotechnology Inc. (Lake Placid, NY, USA); the 
PhosphoPlus p44/42 MAPK and p38 kinase antibody kits were from Cell Signaling 
Technology Inc. (Beverly, MA, USA); the anti-EGFR antibody, anti-phosphotyrosine 
antibody, anti-Akt1/2 antibody, and protein A/G plus-agarose were from Santa Cruz 
Biotechnology, Inc. (Santa Cruz, CA, USA). 
 
Cell Culture 
    The JB6 mouse epidermal cell line, Cl 41, and its stable transfectant, P+1-1 (AP-1 
reporter transfectant), were gifts from Dr. Zigang Dong, the Hormel Institute, University 
of Minnesota, (Austin MN, USA).  The cells were cultured in MEM supplemented 
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with 5% FBS, 2 mM L-glutamine, and 25 µg/ml gentamicin in an incubator at 37°C 
under 5% CO2 in air. 
 
Anchorage-independent growth assay 
    JB6 Cl 41 cells (1×104) were exposed to EGF (20 ng/ml) with or without 
flavonoids at 10 µM in 1 ml of 0.33% BME agar containing 10% FBS over 3.5 ml of 
0.5% BME agar medium containing 10% FBS.  The cultures were maintained in an 
incubator at 37°C under 5% CO2 in air, and the colonies formed were scored under a 
microscope 14 days after exposure to EGF. 
 
Cell growth inhibition assay 
    JB6 Cl 41 cells (5×103) were seeded into each well of 96-well plates and allowed 
to attach overnight.  The cells were then treated with the indicated concentrations of 
flavonoids for 72 h in an incubator at 37°C under 5% CO2 in air.  Subsequently, MTT 
(25 µL of 2 mg/mL) in phosphate-buffered saline (PBS) was added to each well, then 
incubation was continued for 4 h at 37°C.  Formazan crystals were dissolved in 
dimethylsulfoxide.  Absorbance was determined at 540 nm with a microplate reader 
(Multiskan Bichromatic; Labsystems Japan, Tokyo, Japan). 
 
Assay of AP-1 activity 
    JB6 AP-1 reporter stable P+1-1 cells (7×103) were seeded in 96-well plates.  After 
24 h incubation, the cells were starved by replacing the medium with 0.1% FBS/MEM 
for 24 h.  Then, the cells were pretreated with a flavonoid (10 µM) for 1 h and cultured 
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with or without 20 ng/ml EGF in the presence or absence of the flavonoid for 24 h.  
The cells were extracted with lysis buffer, and luciferase activity was measured with a 
BioOrbit 1253 luminometer (Turku, Finland).  Relative AP-1 activity was calculated as 
described previously [26,27,31]. 
 
AP-1 DNA-binding assay 
    JB6 Cl 41 cells were cultured to 80% confluence and then starved by culturing in 
0.1% FBS/MEM for 24 h at 37°C.  The medium was then changed to fresh 0.1% 
FBS/MEM and the cells were incubated for another 2-4 h at 37°C.  Before the cells 
were exposed to EGF, they were treated with or without (control) a flavonoid (10 µM) 
for 1 h.  Then, EGF was added and the cells were incubated for 24 h.  Nuclear protein 
from the cells was extracted, and the DNA binding reaction was performed using 5 µg 
of nuclear protein and 15000 cpm of a 32P-labeled oligonucleotide containing the 
AP-1-binding element (5’-CGC TTG ATG AGT CAG CCG GAA-3’) as described 
previously [26,33].  The samples were separated on 5% polyacrylamide gels, which 
were analyzed using a Typhoon 9410 image analyzer (Amersham Biosciences) and NIH 
image 1.61 software. 
 
Immunoblotting 
    Immunoblotting was carried out as described previously [27,31].  In brief, JB6 Cl 
41 cells were treated with or without a flavonoid (10 µM) for 1 h before treatment with 
EGF (20 ng/ml) for 5 min.  The cells were then lysed, and immunoblotting analysis 
was performed using antibodies against p44/42 MAPKs (ERKs; extracellular-signal 
regulated protein kinases) and p38 kinase antibody or phosphate-specific antibodies 
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against the phosphorylated proteins.  Antibody-bound proteins were detected using an 
ECL-Plus Western Blotting Kit (Amersham Biosciences) and analyzed using a Typhoon 
9410 image analyzer (Amersham Biosciences). 
 
JNK assay 
    JB6 Cl 41 cells were treated with or without a flavonoid (10 µM) for 1 h before 
treatment with EGF (20 ng/ml) for 5 min.  The lysates were then prepared from the 
cells, and immunoprecipitation was carried out using immobilized c-Jun fusion protein 
(Cell signaling).  The kinase assay and immunoblotting using phospho-c-Jun (Ser 63) 
antibody were performed according to the protocol of a JNK assay kit (Cell Signaling).  
The immunoblotting were detected using an ECL-Plus Western Blotting Kit (Amersham 
Biosciences) and analyzed using a Typhoon 9410 image analyzer (Amersham 
Biosciences). 
 
Akt immunoprecipitation kinase assay 
    JB6 Cl 41 cells were treated with or without a flavonoid (10 µM) for 1 h before 
treatment with EGF (20 ng/ml) for 5 min.  The lysates were then prepared from the 
cells, and immunoprecipitation was carried out using 20 µl of anti-Akt1/2 antibody 
(Santa Cruz).  Akt activities were determined using a specific Akt substrate peptide 
and [γ-32P]ATP as described previously [32]. 
 
PI3K assay 
    JB6 Cl 41 cells pretreated with a flavonoid (10 µM) for 1 h were exposed to EGF 
(20 ng/ml) for 5 min.  The cell lysate was normalized against the untreated control, and 
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incubated with gentle rocking for 2 h at 4°C with 20 µl of agarose conjugated with 
anti-tyrosine antibody.  The PI3K activity was determined as described previously [32].  
The radiolabeled spot of phosphatidylinositol 3-phosphate (PIP3) was quantified using a 
Typhoon 9410 image analyzer (Amersham Biosciences) and NIH image 1.61 software.  
 
Direct effects of the flavonoids on PI3K assay 
    JB6 Cl 41 cells treated with EGF (20 ng/ml) in the absence of flavonoids were 
lysed as described above.  The protein immunoprecipitated with agarose-conjugated 
anti-tyrosine antibody was reacted in the presence or absence of a flavonoid (10 µM).  
PI3K activity was determined as above. 
 
RESULTS AND DISCUSSION 
Structure-activity relationship of flavonoids for inhibition of EGF-induced cell 
transformation 
    Mouse epidermal JB6 promotion-sensitive (P+) cell line, Cl 41, in which 
transformed colonies are induced by EGF or TPA [4,21,24,26], is a well-developed 
model to screen chemopreventive agents, and to elucidate their mechanisms at the 
molecular level.  Therefore, we used this cell line in order to investigate the 
structure-activity relationship for inhibition of soft agar colony formation (cell 
transformation) by flavonoids.  EGF induced 2000-3000 transformed colonies in soft 
agar, whereas almost no colony formation was observed in the control group (0.1% 
DMSO).  As shown in Fig. 2, flavones (apigenin, chrysin) and flavanone (naringenin) 
slightly inhibited EGF-induced cell transformation at the concentration of 10 µM.  In 
addition to flavanols, EGCG and theaflavins, which have reported previously (26), 
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flavonols (quercetin, myricetin, quercetagetin, fisetin) were potent inhibitors (Fig. 2), 
and their effect was concentration-dependent (1-10 µM) (data not shown).  On the 
other hand, isoflavones, falavanonols and chalcone had no significant inhibitory effect 
on EGF-induced cell transformation.   
    As shown in Fig. 1, the basic structure of flavonoids is comprised of two benzene 
rings (A- and B-ring) linked through a heterocyclic pyrane or pyrone ring (C-ring) in 
the middle.  The B-ring is usually substituted at the 2-position of the C-ring.  The 
subdivision of flavonoids is primarily based on the presence of an oxy group at position 
4, a double bond between carbon atoms 2 and 3 (C2-C3 double bond), and the presence 
of a hydroxyl group in position 3 (3-OH) of the C-ring.  Flavonols, such as quercetin, 
myricetin, quercetagetin and fisetin, which were potent inhibitors, have all of oxy group 
at position 4, C2-C3 double bond, and 3-OH.  In contrast, chalcone lacks the C-ring, 
and the B-ring of isoflavonoids is substituted at the 3-position of the C-ring.  
Flavanonols do not have C2-C3 double bond.  For example, (±)-taxifolin, which lacks 
the C2-C3 double bond of quercetin in the C-ring, failed to inhibit EGF-induced cell 
transformation.  Thus, it was suggested that the position substituted of the B-ring, the 
presence of the diphenylpropane (C6-C3-C6) skeleton, and the presence of C2-C3 
double bond are important for the cell transformation.  Flavones, which lack 3-OH, 
and flavanones, which do not have 3-OH and C2-C3 double bond, only showed the 
weak inhibitory effect for cell transformation.  In addition, luteolin, which lacks 3-OH, 
or rutin, which has a glycoside in place of the 3-OH on the C-ring of quercetin, showed 
no significant inhibitory effect on EGF-induced transformation, suggested that the 3-OH 
on the C-ring is related to the cell transformation.  Furthermore, the flavanols, 
quercetin, myricetin, quercetagetin and fisetin, have 3’- and 4’- OH on the B-ring, and 
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elimination of 3’-OH on the B-ring, as in kaempferol and morin, reduced the inhibitory 
potency compared with quercetin.  Flavanols, such as (+)- and (-)-catechin, which do 
not have the oxy group at position 4 and C2-C3 double bond, were ineffective, although 
EGCG and theaflavins, which contain the galloyl group, showed a strong inhibitory 
effect.  Therefore, the galloyl group was considered to be important for the inhibitory 
effects of EGCG and theaflavins on cell transformation.  As summarized in Fig. 3, 
these findings indicated that the important structural features of flavonoids for inhibition 
of EGF-induced cell transformation are as follows: 1) 3’- and 4’-OH on the B-ring, 2) 
3-OH on the C-ring, 3) the C2-C3 double bond in the C-ring, and 4) the 
phenylchromone (C6-C5-C6) skeleton in the flavonoids, and 5) the galloyl group in 
EGCG and theaflavins.   
    Among the flavonoids, quercetagetin showed growth inhibition, suggesting that the 
cell transformation-inhibitory action of quercetagetin resulted at least partly from 
growth inhibition or apoptosis (Fig. 4).  We have observed that the growth-inhibitory 
effect of baicalein, 5,6,7-trihydroxy-flavone, was stronger than that of quercetagetin in 
the same concentration range (data not shown), suggesting that 6-OH on the A-ring is 
involved in the growth-inhibitory effect of flavonoids.   
 
Flavonoids inhibited EGF-induced activation and DNA-binding activity of AP-1      
    The transcription factor AP-1 plays a critical role in neoplastic transformation in 
JB6 P+ cells, as well as in tumor promotion [15,21,23,26].  It has been reported that 
EGCG and theaflavins inhibited EGF-induced AP-1 activation as well as cell 
transformation [26].  We then studied the effects of the above flavonoids on 
EGF-induced AP-1 activation using a luciferase-reporter gene assay.  In addition to 
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EGCG and theaflavins, the flavonols, quercetin, myricetin, quercetagetin and fisetin, 
suppressed EGF-induced AP-1 activity without inhibition of basal activity of AP-1 (Fig. 
5).  
    AP-1 induces gene transcription by binding to the TPA response element (AP-1 
binding site) in the promoter region of its target genes [23].  As shown in Fig. 6, the 
flavonols inhibited AP-1 DNA-binding activity, as well as AP-1 activation, suggesting 
that the inhibition of EGF-induced cell transformation by the flavonoids involves the 
blocking of AP-1 activation.  The flavonoids did not directly inhibit AP-1 
DNA-binding activity (data not shown).     
    AP-1 activation is stimulated, at least in part, by activation of MAPKs, such as 
ERKs, JNKs, and p38 kinases [24,25].  Dong et al. [26] showed that EGCG and 
theaflavins blocked EGF-induced AP-1 activation through the inhibition of JNKs 
activation in JB6 Cl 41 cells.  Although the six flavonoids had no effect on 
EGF-induced phosphorylation of ERKs and p38 kinases, JNKs activities decreased by 
treatment with the flavonoids (Fig. 7).  Therefore, inhibition of AP-1 activation by 
flavonols (quercetin, myricetin, quercetagetin and fisetin) was suggested to be, at least 
in part, through the inhibition of JNKs activation as well as EGCG and theaflavins. 
 
Quercetin, myricetin, quercetagetin, EGCG and theaflavins inhibited EGF-induced 
activation of PI3K and Akt 
    PI3K is central to the coordinated control of multiple cell-signaling pathways 
leading to tumor development [28,29], and Akt, a downstream effector of PI3K, plays a 
pivotal role in the PI3K-signaling pathway [30].  We have shown that overexpression 
of a dominant negative mutant of Akt1, which antagonizes Akt function, and a PI3K 
 13
inhibitor, LY294002, block EGF-induced cell transformation in JB6 Cl 41 cells [27].  
Therefore we assessed the effects of the flavonoids (quercetin, myricetin, quercetagetin, 
fisetin, EGCG, and theaflavins) on EGF-induced Akt activation.  As shown in Fig. 8, 
quercetin, myricetin, quercetagetin, EGCG, and theaflavins, but not fisetin, clearly 
suppressed EGF-induced activation of Akt.  On the other hand, none of the flavonoids 
directly inhibited Akt activation induced by EGF (data not shown).   
    Quercetin, myricetin, quercetagetin, fisetin, EGCG and theaflavins also 
significantly suppressed EGF-induced PI3K activation (Fig. 9).  On the other hand, 
fisetin did not inhibit PI3K activation.  We further tested whether these flavonoids 
directly inhibited PI3K activation.  The results show that myricetin, quercetagetin, 
fisetin, EGCG and theaflavins, but not quercetin and fisetin, directly blocked 
EGF-induced PI3K activation (Fig. 10), suggesting that myricetin, quercetagetin, EGCG 
and theaflavins inhibit activation of PI3K and Akt by direct inhibition of PI3K.  It has 
been reported that some flavonoids inhibit PI3K activity through competition with ATP 
at its binding site [10,14].  Therefore, the inhibition of PI3K activation by the 
flavonoids may be due to competing with ATP for binding to PI3K.  Although 
quercetin was demonstrated to block ATP binding to PI3K [14], the concentration (10 
μM) examined here with JB6 Cl 41 cells did not directly inhibit PI3K activation.  
Quercetin might inhibit PI3K activation through suppression of the binding of PI3K to 
the EGF receptor.  Our results confirmed that the C2-C3 double bond in the C-ring, 
and the 3’- and 4’-OH moieties on the B-ring of the flavonids (flavonols) have 
important roles in the inhibition of PI3K activation [10,14], and also in blocking cell 
transformation.  In addition, the presence of 5-OH on the A-ring may be critical for the 
inhibitory action, because fisetin did not suppress PI3K activation.  Epicatechin, (+)- 
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and (-)-catechin had no effect on EGF-induced PI3K activation (data not shown).  
Therefore, the galloyl group in EGCG and theaflavins is suggested to be involved in the 
inhibition of PI3K.  On the other hand, fisetin, which did not inhibit PI3K activation, 
may have other targets; for instance, specific targets downstream of the PI3K pathway, 
or some other signaling cascade. 
    We also study on inhibitory mechanisms of flavonoids on insulin-stimulated 
intracellular signaling in mouse preadipose MC3T3-G2/PA6 cells differentiated into 
mature adipose cells.  In that study, we found that some flavones and flavonols (10 
μM), including apigenin, quercetin and fisetin, suppressed insulin-stimulated activation 
of PI3K/Akt pathway through inhibition of tyrosine phosphorylation of insulin receptor 
β-subunit.  EGCG and theaflavins had no effects on the activation of PI3K/Akt 
pathway.  In addition, quercetin, myricetin, quercetagetin, fisetin, EGCG and 
theaflavins did not inhibit EGF-stimulated Akt phosphorylation in the differentiated 
MC3T3-G2/PA6 cells at the concentration of 10 µM (data not shown).  These findings 
suggested that the inhibition of PI3K/Akt pathway by flavonoids might be tumor 
specific.   
    
    In summary, our results indicate that flavonols (quercetin, myricetin, quercetagetin 
and fisetin) and flavanols (EGCG and theaflavins) markedly inhibit EGF-induced cell 
transformation.  The inhibitory effects were suggested to be due to blockade of 
EGF-induced activation of AP-1 and PI3K, except in the case of fisetin, which did not 
block PI3K activation.  The structure-activity relationship indicated that the C2-C3 
double bond in the C-ring, and the 3’- and 4’-OH moieties on the B-ring in the flavonols, 
and the presence of a galloyl group are important for the inhibition of cell 
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transformation and protein kinases.  In addition, a hydroxyl group on the chroman 
nucleus (A- and B-ring), such as 3-OH or 5-OH, may also play a significant role in 
determining the specificity of the bioactivities of the flavonoids.  The results of the 
present study may help to provide a rational basis for the design of novel cancer 
chemopreventive agents.   
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FIGURE LEGENDS 
    Fig. 1a.  Structures of Flavonoids.  
 
Fig. 1b.  Structures of Flavonoids (continued). 
 
Fig. 1c.  Structures of Flavonoids (continued). 
 
Fig. 2.  Effects of flavonoids on EGF-induced cell transformation.  Aliquots of 
104 JB6 Cl 41 cells were treated with EGF (20 ng/ml) with or without 10 µM 
flavonoid in 0.33% BME agar containing 10% FBS over 0.5% BME agar medium 
containing 10% FBS.  Cell colonies were scored after incubation for 14 days at 37˚C 
under 5% CO2 in air.  Data are expressed as means ± S.E. of at least four experiments.  
*, ** Significantly different from EGF alone at P < 0.05 and P < 0.001, respectively.   
 
Fig. 3.  Relationship between flavonoid structure and cell 
transformation-inhibitory activity.  Important structural features of flavonoids for cell 
transformation-inhibitory activity are 3’- and 4’-OH on the B-ring, 3-OH on the C-ring, 
C2-C3 double bond in the C-ring, and the phenylchromone (C6-C5-C6) skeleton in the 
flavonols, and the galloyl group in EGCG and theaflavins. 
 
Fig. 4.  Effects of flavonoids on cell growth.  JB6 Cl 41 cells were treated with 
the indicated concentration of transformation-inhibitory flavonoids for 72 h.  Data are 
expressed as means ± S.E. of at least three experiments. 
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Fig. 5.  Effect of the flavonoids on EGF-induced AP-1 activation.  JB6 AP-1 
reporter stable P+1-1 cells were exposed or not exposed to 20 ng/ml EGF with or 
without flavonoid (10 µM) for 24 h.  The results are shown as relative AP-1 activity, 
expressed as means ± S.E. of at least three experiments.  * Significantly different from 
EGF alone at P < 0.001.   
 
Fig. 6.  Effect of the flavonoids on EGF-induced AP-1 DNA-binding activity.  
After pretreatment with or without a flavonoid (10 µM) for 1 h, JB6 Cl 41 cells were 
treated with or without EGF (20 ng/ml) and subsequently incubated for 24 h.  Nuclear 
protein was extracted, and the sequence-specific AP-1 DNA binding activity was 
determined by gel-shift analysis using a 32P-labeled oligonucleotide containing the 
AP-1-binding element. Data are expressed as the means ± S.E. of three experiments.  
*Significantly different from EGF alone at P < 0.05. 
  
Fig. 7.  Effect of the flavonoids on EGF-induced activation of MAPKs.  JB6 Cl 
41 cells were pretreated with flavonoid (10 µM) for 1 h.  The cells were then treated or 
untreated with EGF (20 ng/ml) and subsequently cultured for 5 min.  The 
phosphorylation levels were estimated by immunoblotting as described in 
“MATERIALS AND METHODS”. 
 
Fig. 8.  Effect of the flavonoids on EGF-induced Akt activation.  After treatment 
with or without a flavonoid (10 µM), JB6 Cl 41 cells were treated with or without EGF 
(20 ng/ml) and subsequently incubated for 5 min.  The respective activities were 
assessed using a specific substrate peptide and [γ-32P]ATP.  Data are expressed as the 
 18
means ± S.E. of six experiments.  *Significantly different from EGF alone at P < 0.05. 
 
Fig. 9.  Effect of the flavonoids on EGF-induced PI3K activation.  After 
treatment with or without a flavonoid (10 µM) for 1 h, JB6 Cl 41 cells were treated with 
or without EGF (20 ng/ml) and subsequently incubated for 5 min.  The cells were 
lysed and PI3K activity was determined as described in “MATERIALS AND 
METHODS”.  Data are expressed as the means ± S.E. of five experiments.  
*Significantly different from EGF alone at P < 0.05.   
 
Fig. 10.  Direct effects of the flavonoids on EGF-induced PI3K activation.  JB6 
Cl 41 cells were treated with or without EGF (20 ng/ml) for 5 min.  The cells were 
lysed and the immunoprecipitated protein was allowed to react in the presence or 
absence of flavonoid (10 µM).  Activities of PI3K were determined as described in 
“MATERIALS AND METHODS”.   Data are expressed as the means ± S.E. of three 
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Fig. 1c.  Ichimatsu et al.
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C2-C3 double bond in C-ring
Phenylchromone (C6-C3-C6) skeleton
































































Fig. 4.  Ichimatsu et al.


































































































































































































Fig. 7.  Ichimatsu et al.




























































































































































Fig. 10.  Ichimatsu et al.
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